Current treatment status-Did not start treatment yet - Page 28 of 37 Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Long-term effects of early prostate cancer treatment

Posted by on Jan 29, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the long-term effects of early prostate cancer treatment. Some background Early prostate cancer is usually treated with active surveillance, radiation therapy, androgen deprivation therapy or surgery. Active surveillance involves the monitoring of cancer progression in a patient without administering...

Read More

Imaging technology can be used in active surveillance to monitor prostate cancer

Posted by on Jan 20, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine how effective magnetic resonance imaging is in monitoring patients with prostate cancer undergoing active surveillance. Some background Active surveillance is used in patients with favorable-risk prostate cancer (very low or low risk – cancer cannot be felt or seen by imaging or is localised to...

Read More

Nivolumab – a new treatment option in melanoma

Nivolumab – a new treatment option in  melanoma

Posted by on Dec 11, 2014 in Melanoma | 0 comments

In a nutshell The authors aimed to determine whether nivolumab (Opdivo) can improve survival in advanced melanoma patients without the BRAF mutation.  Some background Nivolumab is a man-made immune cell (protects the body from disease). It works by blocking a protein called programmed cell death 1 (PD-1) that is found on active immune...

Read More

Comparing outcomes for patients with EGFR mutations: New drug (afatinib) vs standard therapy

Posted by on Nov 27, 2014 in Lung cancer | 0 comments

In a nutshell This study compared the outcomes between the standard chemotherapy treatment for advanced non-small-cell lung cancer and a new drug, afatinib (Gilotrif, Giotrif) in Asian populations.  Some background Non-small-cell lung cancer (NSCLC) is a common type of lung cancer but can be difficult to treat. Standard treatment involves...

Read More

How important is electronic tumor tracking?

How important is electronic tumor tracking?

Posted by on Nov 25, 2014 in Prostate cancer | 0 comments

In a nutshell This report discusses using a device to track tumor sites in follow-up biopsies in prostate cancer.  Some background Biopsies (the removal of tissue from the body and examination to establish the presence of cancer) are a very important part of active surveillance (patient monitoring instead of treatment) in early prostate...

Read More